Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR/EST pathway-Reference-Cited by-同舟云学术

Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR/EST pathway

Published:2023-05 Issue: Volume:47 Page:189-207
ISSN:2090-1232
Container-title:Journal of Advanced Research
language:en
Short-container-title:Journal of Advanced Research

Author:

Zhang Juping,Wang Neng,Zheng Yifeng,Yang Bowen,Wang Shengqi,Wang Xuan,Pan Bo,Wang Zhiyu

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference49 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;Ca-a Cancer Journal for Clinicians,2021

2. Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women;Sampson;Cancer Res,2017

3. Associations of the Fecal Microbiome With Urinary Estrogens and Estrogen Metabolites in Postmenopausal Women;Fuhrman;J Clin Endocrinol Metab,2014

4. Breast Cancer Treatment;Waks;JAMA,2019

5. Urinary estrogen metabolites in the luteal phase and subsequent risk of breast cancer among premenopausal women;Eliassen;Cancer Res,2010

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of omics technologies in studies on antitumor effects of Traditional Chinese Medicine;Chinese Medicine;2024-09-09

2. The intersection of the nervous system and breast cancer;Cancer Letters;2024-08

3. Naringenin as potent anticancer phytocompound in breast carcinoma: from mechanistic approach to nanoformulations based therapeutics;Frontiers in Pharmacology;2024-06-18

4. Guideline of traditional Chinese medicine diagnosis and treatment for breast cancer patients with emotional disorders (2023);Guidelines and Standards of Chinese Medicine;2024-06

5. Developing liver-targeted naringenin nanoparticles for breast cancer endocrine therapy by promoting estrogen metabolism;Journal of Nanobiotechnology;2024-03-19